As we close out 2019 with this December edition of our Updates on Myeloproliferative Neoplasms (MPNs) newsletter, I encourage you to read through previous editions and refresh yourself on all the year’s important news and research in the field, as well as our video Q&A archives. And don’t forget about the MPN Resources Center—full of helpful tools and guidelines to empower your practice and your patients.
In this edition, check out the newest curated list of MPN news and research, including data on the association between MPN therapies and birth rate, metabolic effects of JAK1/2 inhibition, and ongoing studies of ruxolitinib for patients with PV.
Please continue sending in your questions, comments, and suggestions to email@example.com. I wish you all the best for a happy and healthy new year!
Lindsey Lyle, MS, PA-C
Senior Instructor, Blood Cancers and Bone Marrow Transplant Program
University of Colorado, Anschutz Medical Campus